Related Experiment Videos
Update on rimonabant--a selective cannabinoid CB1 antagonist
The Annals of Pharmacotherapy
|April 28, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Taranabant, a novel cannabinoid type 1 receptor inverse agonist.
Current opinion in investigational drugs (London, England : 2000)·2008
Medication therapy management survey of the prescription drug plans.
Journal of the American Pharmacists Association : JAPhA·2006
The endocannabinoid system.
Pharmacotherapy·2006
Outcomes of pharmacist-managed diabetes care services in a community health center.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2006
Exercise for low-income patients with diabetes: a continuous quality improvement project.
The Diabetes educator·2006
Rimonabant--a selective CB1 antagonist.
The Annals of pharmacotherapy·2005
Description of Treatment Strategies and Patient Outcomes for Hospitalized Patients With Lyme Carditis.
The Annals of pharmacotherapy·2026
Zopapogene Imadenovec-Drba for Recurrent Respiratory Papillomatosis.
The Annals of pharmacotherapy·2026
Characterization of Antidiabetic Medication Prescribing After Hospital Discharge in US Critically Ill Adults.
The Annals of pharmacotherapy·2026
Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus Penicillium herquei.
Journal of Asian natural products research·2026
The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.
Frontiers in behavioral neuroscience·2026
Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?
Expert opinion on pharmacotherapy·2026
Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.
Endocrine, metabolic & immune disorders drug targets·2026